
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immune response and safety to inactivated COVID-19 vaccine: a comparison between people living with HIV and HIV-naive individuals
Shi Zou, Mengmeng Wu, Fangzhao Ming, et al.
AIDS Research and Therapy (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 25
Shi Zou, Mengmeng Wu, Fangzhao Ming, et al.
AIDS Research and Therapy (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 25
Showing 25 citing articles:
Recent review of COVID-19 management: diagnosis, treatment and vaccination
Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1120-1148
Open Access | Times Cited: 55
Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1120-1148
Open Access | Times Cited: 55
Trends in COVID-19 admissions and deaths among people living with HIV in South Africa: analysis of national surveillance data
Waasila Jassat, Caroline Mudara, Lovelyn Ozougwu, et al.
The Lancet HIV (2024) Vol. 11, Iss. 2, pp. e96-e105
Closed Access | Times Cited: 9
Waasila Jassat, Caroline Mudara, Lovelyn Ozougwu, et al.
The Lancet HIV (2024) Vol. 11, Iss. 2, pp. e96-e105
Closed Access | Times Cited: 9
Immunogenicity and efficacy of COVID-19 vaccines in people living with HIV: a systematic review and meta-analysis
Juntao Yin, Yangyang Chen, Yang Li, et al.
International Journal of Infectious Diseases (2022) Vol. 124, pp. 212-223
Open Access | Times Cited: 31
Juntao Yin, Yangyang Chen, Yang Li, et al.
International Journal of Infectious Diseases (2022) Vol. 124, pp. 212-223
Open Access | Times Cited: 31
Correlation between CD4 T-Cell Counts and Seroconversion among COVID-19 Vaccinated Patients with HIV: A Meta-Analysis
Qian Zhou, Yihuang Liu, Furong Zeng, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 789-789
Open Access | Times Cited: 13
Qian Zhou, Yihuang Liu, Furong Zeng, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 789-789
Open Access | Times Cited: 13
A Review of Inactivated COVID-19 Vaccine Development in China: Focusing on Safety and Efficacy in Special Populations
Lidan Hu, Jingmiao Sun, Yan Wang, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1045-1045
Open Access | Times Cited: 12
Lidan Hu, Jingmiao Sun, Yan Wang, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1045-1045
Open Access | Times Cited: 12
Serological response following COVID-19 vaccines in patients living with HIV: a dose–response meta-analysis
Qian Zhou, Furong Zeng, Yu Meng, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Qian Zhou, Furong Zeng, Yu Meng, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
SARS-CoV-2 immunity and vaccine strategies in people with HIV
Claire Mullender, Kelly A. S. da Costa, Aljawharah Alrubayyi, et al.
Oxford Open Immunology (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 16
Claire Mullender, Kelly A. S. da Costa, Aljawharah Alrubayyi, et al.
Oxford Open Immunology (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 16
Humoral immune response to inactivated COVID-19 vaccination at the 3rd month among people living with HIV
Songjie Wu, Shi Zou, Fangzhao Ming, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Songjie Wu, Shi Zou, Fangzhao Ming, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Safety and immunogenicity of homologous prime‐boost CoronaVac vaccine in people living with HIV in China: A multicenter prospective cohort study
Yuxiao Wang, Xinquan Lan, Ying Qiao, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Closed Access | Times Cited: 2
Yuxiao Wang, Xinquan Lan, Ying Qiao, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Closed Access | Times Cited: 2
Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV
Shi Zou, Wei Guo, Songjie Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Shi Zou, Wei Guo, Songjie Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Comparative immunogenicity and neutralizing antibody responses post heterologous vaccination with CoronaVac (Sinovac) and Vaxzevria (AstraZeneca) in HIV-infected patients with varying CD4+ T lymphocyte counts
Sorawit Chittrakarn, Pisud Siripaitoon, Sarunyou Chusri, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Sorawit Chittrakarn, Pisud Siripaitoon, Sarunyou Chusri, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Hospitalizations for Acute Otitis and Sinusitis in Patients Living with HIV: A Retrospective Analysis of a Tertiary Center in Romania
Vlad Ștefan Pleșca, Victor Daniel Miron, Adrian Gabriel Marinescu, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 11, pp. 3346-3346
Open Access | Times Cited: 1
Vlad Ștefan Pleșca, Victor Daniel Miron, Adrian Gabriel Marinescu, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 11, pp. 3346-3346
Open Access | Times Cited: 1
Advances in Research on COVID-19 Vaccination for People Living with HIV
Junyan Jin, Xiuwen Wang, Raphaël Carapito, et al.
Infectious Diseases & Immunity (2022) Vol. 2, Iss. 4, pp. 213-218
Open Access | Times Cited: 8
Junyan Jin, Xiuwen Wang, Raphaël Carapito, et al.
Infectious Diseases & Immunity (2022) Vol. 2, Iss. 4, pp. 213-218
Open Access | Times Cited: 8
Mads Herluf Søndergaard, Jannifer Jasmin Thavarajah, Henry Henson, et al.
HIV Medicine (2023) Vol. 25, Iss. 1, pp. 16-37
Open Access | Times Cited: 4
HIV infection and the implication for COVID‐19 vaccination
Tope Oyelade, Reynie Purnama Raya, Kamaluddin Latief
Public Health Challenges (2022) Vol. 1, Iss. 3
Open Access | Times Cited: 7
Tope Oyelade, Reynie Purnama Raya, Kamaluddin Latief
Public Health Challenges (2022) Vol. 1, Iss. 3
Open Access | Times Cited: 7
Immunogenicity and safety of COVID-19 vaccines among people living with HIV: A systematic review and meta-analysis
Tian-Yu Zhao, Zongxing Yang, Yuxia Wu, et al.
Epidemiology and Infection (2023) Vol. 151
Open Access | Times Cited: 3
Tian-Yu Zhao, Zongxing Yang, Yuxia Wu, et al.
Epidemiology and Infection (2023) Vol. 151
Open Access | Times Cited: 3
A tale of two conditions: when people living with HIV meet three doses of inactivated COVID-19 vaccines
Yuting Tan, Shi Zou, Fangzhao Ming, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Yuting Tan, Shi Zou, Fangzhao Ming, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Efficacy, Safety, and Public Attitude toward COVID-19 Vaccines: A Systematic Review
Blessing Osagumwendia Josiah, Chinelo C. Uzor, Brontie A. Duncan, et al.
Annals of African Medicine (2023) Vol. 22, Iss. 4, pp. 405-414
Open Access | Times Cited: 2
Blessing Osagumwendia Josiah, Chinelo C. Uzor, Brontie A. Duncan, et al.
Annals of African Medicine (2023) Vol. 22, Iss. 4, pp. 405-414
Open Access | Times Cited: 2
Clinical course, management and outcomes of COVID-19 in HIV-infected renal transplant recipients: A case series
Luc Bertels, Kathryn Manning, Andrew D. Redd, et al.
South African Medical Journal (2024), pp. e1374-e1374
Open Access
Luc Bertels, Kathryn Manning, Andrew D. Redd, et al.
South African Medical Journal (2024), pp. e1374-e1374
Open Access
People living with HIV with the Omicron variant infection have milder COVID-19 symptoms: results from a cross-sectional study
Yuting Tan, Songjie Wu, Fangzhao Ming, et al.
AIDS Research and Therapy (2024) Vol. 21, Iss. 1
Open Access
Yuting Tan, Songjie Wu, Fangzhao Ming, et al.
AIDS Research and Therapy (2024) Vol. 21, Iss. 1
Open Access
Correction: Immune response and safety to inactivated COVID-19 vaccine: a comparison between people living with HIV and HIV-naive individuals
Shi Zou, Mengmeng Wu, Fangzhao Ming, et al.
AIDS Research and Therapy (2024) Vol. 21, Iss. 1
Open Access
Shi Zou, Mengmeng Wu, Fangzhao Ming, et al.
AIDS Research and Therapy (2024) Vol. 21, Iss. 1
Open Access
Serological response following COVID-19 vaccines in patients living with HIV: a dose-response meta- analysis
Qian Zhou, Furong Zeng, Yu Meng, et al.
Research Square (Research Square) (2023)
Open Access
Qian Zhou, Furong Zeng, Yu Meng, et al.
Research Square (Research Square) (2023)
Open Access
Safety and Immunogenicity of SARS-CoV-2 Vaccines in People Living With HIV: A Systematic Review and Meta-analysis of Real-World Studies
Xueying Fan, Yangguo Zhao, Fan Wu, et al.
Infectious Microbes & Diseases (2023)
Open Access
Xueying Fan, Yangguo Zhao, Fan Wu, et al.
Infectious Microbes & Diseases (2023)
Open Access
Uptake and impact of COVID-19 vaccination among HIV key populations: a cohort study from Tamil Nadu, India
Muhammad Umer Saleem, Janakiram Marimuthu, Aravind P. Gandhi
Journal of Rural Medicine (2023) Vol. 18, Iss. 4, pp. 215-221
Open Access
Muhammad Umer Saleem, Janakiram Marimuthu, Aravind P. Gandhi
Journal of Rural Medicine (2023) Vol. 18, Iss. 4, pp. 215-221
Open Access
Safety profiles of homologous and heterologous regimens containing three major types of COVID-19 vaccine among people living with HIV
Thana Khawcharoenporn, Sirashat Hanvivattanakul
International Journal of STD & AIDS (2023) Vol. 35, Iss. 4, pp. 262-273
Closed Access
Thana Khawcharoenporn, Sirashat Hanvivattanakul
International Journal of STD & AIDS (2023) Vol. 35, Iss. 4, pp. 262-273
Closed Access